Open Access

Non enzymatic upregulation of tissue factor expression by gamma-glutamyl transferase in human peripheral blood mononuclear cells

  • Valentina Scalise1,
  • Cristina Balia1,
  • Silvana Cianchetti1,
  • Tommaso Neri1,
  • Vittoria Carnicelli1,
  • Riccardo Zucchi1,
  • Maria Franzini2,
  • Alessandro Corti2,
  • Aldo Paolicchi2,
  • Alessandro Celi1 and
  • Roberto Pedrinelli1Email authorView ORCID ID profile
Thrombosis Journal201614:45

DOI: 10.1186/s12959-016-0119-8

Received: 11 August 2016

Accepted: 26 October 2016

Published: 4 November 2016

Abstract

Background

Besides maintaining intracellular glutathione stores, gamma-glutamyltransferase(GGT) generates reactive oxygen species and activates NFkB, a redox-sensitive transcription factor key in the induction of Tissue Factor (TF) gene expression, the principal initiator of the clotting cascade. Thus, GGT might be involved in TF-mediated coagulation processes, an assumption untested insofar.

Methods

Experiments were run with either equine, enzymatically active GGT or human recombinant (hr) GGT, a wheat germ-derived protein enzymatically inert because of missing post-translational glycosylation. TF Procoagulant Activity (PCA, one-stage clotting assay), TF antigen(ELISA) and TFmRNA(real-time PCR) were assessed in unpooled human peripheral blood mononuclear cell(PBMC) suspensions obtained from healthy donors through discontinuous Ficoll/Hystopaque density gradient.

Results

Equine GGT increased PCA, an effect insensitive to GGT inhibition by acivicin suggesting mechanisms independent of its enzymatic activity, a possibility confirmed by the maintained stimulation in response to hrGGT, an enzymatically inactive molecule. Endotoxin(LPS) contamination of GGT preparations was excluded by heat inactivation studies and direct determination(LAL method) of LPS concentrations <0.1 ng/mL practically devoid of procoagulant effect. Inhibition by anti-GGT antibodies corroborated that conclusion. Upregulation by hrGGT of TF antigen and mRNA and its downregulation by BAY-11-7082, a NFkB inhibitor, and N-acetyl-L-cysteine, an antioxidant, was consistent with a NFkB-driven, redox-sensitive transcriptional site of action.

Conclusions

GGT upregulates TF expression independent of its enzymatic activity, a cytokine-like behaviour mediated by NFκB activation, a mechanism contributing to promote acute thrombotic events, a possibility in need, however, of further evaluation.

Keywords

Gamma-glutamyltransferase Tissue Factor Cytokines Oxidative Stress NFkB

Background

Gamma-glutamyltransferase [GGT; (5-l-glutamyl)-peptide⁄amino acid 5-glutamyl transferase; EC 2.3.2.2], a member of the structural superfamily of the N-terminal nucleophilic hydrolases expressed by a wide number of cell types [1] including circulating monocytes [2, 3], hydrolyzes extracellular glutathione (GSH) to provide cysteine for its intracellular re-synthesis. Along with its pivotal role in that antioxidant biological process [1], however, GGT also generates reactive oxygen species (ROS) [4] and activates NFkB [5, 6], a redox-sensitive transcription factor [7] key in Tissue Factor (TF) gene expression [8], a major regulator of haemostasis and thrombosis [8, 9]. Therefore, deductive reasoning makes it plausible to hypothesize a cross-talk between GGT and TF, a possibility consistent with the highly consistent epidemiological association of circulating GGT levels with acute coronary events (see [10] for a review), a pathological process favoured by TF (see [11] for a review). The assumption, corroborated by recent reports of enzymatically active protein in human atheromatous plaques [12], requires, however, to document a mechanistic link between GGT and TF for which at the moment no evidence is available.

Aims

On the basis of that background, our aim was to evaluate the relationship between GGT and TF expression in human peripheral blood mononuclear cell (PBMC)s, a cell preparation capable of rapid TF induction in response to various proinflammatory stimuli [8].

Methods

Chemicals and standards

Unless stated otherwise, all reagents were from Sigma, Milano, Italy.

Cell isolation and culture

Human PBMC suspensions were obtained from unpooled buffy coats left over from blood bank draws taken from healthy donors with the approval of the local ethics committee of the Azienda Ospedaliero Universitaria Pisana, kept at room temperature and utilized within a maximum of 4 h from withdrawal. As detailed elsewhere [13], leukocytes were isolated from fresh buffy coats diluted 1:1 with sodium citrate 0.38 % in saline solution, mixed gently with 0.5 volume of 2 % Dextran T500 and left for 40 min for erythrocyte sedimentation. The leukocyte-rich supernatant was recovered and centrifuged for 10 min at 200xg. The pellet was resuspended in 30 mL of sodium citrate solution, layered over 15 mL of Ficoll-Hypaque and centrifuged for 30 min at 400xg at 20 °C. The PBMC-rich ring (3×106 cells/mL) was recovered, washed twice in sodium citrate 0.38 % and resuspended in polypropylene tubes in no glucose RPMI 1640 medium supplemented with 100 U/mL penicillin-streptomycin.

All reagents and solutions used for cell isolation and cultures were prepared with endotoxin-free water and glassware was rendered endotoxin-free by exposure to high temperature. Drugs were kept in stock solution and diluted in serum-free RPMI at the appropriate concentrations immediately before use. Cell viability, as assessed by dimethyl thiazolyl diphenyl tetrazolium (MTT), was verified (>85 % of viable cells) throughout all experimental phases.

The final PBMC preparations typically contain 25–35 % monocytes, negligible proportions of neutrophils (<5 %) and 65–75 % lymphocytes, a cell line with some but limited procoagulant potential [14]. Moreover, interferences from contaminating platelets [15] were excluded by absent procoagulant activity in clotting assays carried out in PBMC-free preparations as verified in pilot experiments, so that stimulated TF expression should be considered by and large a result of activated monocytes.

GGT

GGT experiments were carried out by using either equine, enzymatically active GGT purified according to already described procedures [16], or human recombinant(hr)GGT (Abnova, Taipei, Taiwan), a protein synthesized by wheat germ eukaryotic translational apparatuses in which lack of post-translational glycosylation forbids the generation of enzymatically active molecules [17, 18]. Confirming that assumption, GSH as measured by standard methods [19] was not cleaved by hrGGT in contrast with the hydrolysis induced by equine GGT, an effect this latter abolished by acivicin (10−4 M), a glutamate analogue with potent, non competitive GGT inhibiting properties [20], inactive on hrGGT (Fig. 1).
Fig. 1

Absent hydrolytic effect of hrGGT (0.5 μg/mL) in contrast with the complete GSH cleavage obtained by equine GGT (100 mU/mL) reversed by acivicin (ACI, 10−4M), an irreversible GGT inhibitor [20] inactive on hrGGT. Results from a single experimental set after overnight GSH incubation and expressed as percent changes from control. GSH was measured according to standard methods [19]

To exclude interferences from endotoxin (LPS) contamination [21], experiments were carried out with GGT preparations boiled for 30 min before their addition to PBMCs, a procedure expected to abrogate the biological effect of GGT but not the procoagulant power of heat-resistant LPS [21]. In the light of heat sensitivity of some LPS strains [22], endotoxin concentration was also measured in hrGGT-primed cultures by LAL (Limulus Amebocyte Lysate) chromogenic endpoint assay (Hycult Biotech, Uden, The Netherlands) [23] and the procoagulant effect of contaminant LPS levels was then tested in quiescent PBMCs. Finally, we assessed the effect of hrGGT-inhibition by an anti-GGT polyclonal antibody (Abnova, Taipei, Taiwan), 2.5 μg/mL, a concentration chosen according to preliminary concentration-response experiments (not shown), as compared with the appropriate isotype IgG control.

The role of NFkB was indirectly assessed by using BAY-11-7082 (10−5M), a validated NFkB inhibitor [24], as well as N-acetyl-L-cysteine (NAC, 10−3M), an antioxidant with inhibitory effect on NFkB [25].

Experimental methods

TF Procoagulant Activity (PCA)

PCA was assessed by a one-stage clotting time test in PBMCs disrupted by three freeze–thaw cycles as reported previously [26]. Disrupted cells (100 μL) were mixed with 100 μL of normal human plasma at 37 °C, adding 100 μl of 25 mM CaCl2 at 37 °C. Time to clot formation was recorded and values converted to arbitrary units (AU) by comparison with a standard human brain TF calibration curve covering clotting times from 20 to 600 s. The standard TF preparation was arbitrarily assigned a value of 1000 AU/mL and a representative conversion of clotting times to AU is as follows: 100 AU-21 s, 10 AU-40s, 1 AU-82 s, 0.1-187 s, 0.01 AU-375 s, 0.001 AU-600 s.

“Baseline” values were defined as clotting times above 375 s (0.01 AU) and refer to quiescent, non activated, untreated PBMCs. Experiments were run in triplicate and averaged.

TF antigen(ag)

Cells were disrupted by three repeated freeze–thaw cycles and debris pelleted by centrifugation at 100xg for 1 h at 4 °C and supernatants used for ELISA according to manufacturer’s instructions (Imubind TF kit Sekisui Diagnostics, West Malling, United Kingdom). Within and between assay variability was 3.5 and 5.5 %, respectively.

TF mRNA

Total RNA was extracted from PBMCs using the RNeasy mini kit (Qiagen, Hilden, Germany). RNA concentration and purity were determined by optical density measurement via Nanodrop (Thermo Fisher Scientific, Wilmington, Delaware USA). A mixture of 0.5 ng total RNA per sample was retro-transcribed with random primer-oligodT into complementary DNA (cDNA) using the Quantitect Reverse Transcription Kit (Qiagen, Hilden, Germany). The retro-transcription cycle was performed at 25 °C for 5 min, 42 °C for 30 min and 95 °C for 3 min. RealTime-PCR was carried out in a iQ5 Real Time PCR System and SsoAdvanced Sybr Green Supermix (Bio-Rad Laboratories, Hercules, CA) was employed on the basis of the manufacturer’s conditions: 95 °C, 30s; 40 cycles 95 °C, 5 s, 60 °C, 15 s;a final melting protocol with ramping from 65 °C to 95 °C with 0,5 °C increments of 5 s was performed. The primers sequence for RealTime-PCR were: TF, sense 5’-TTGGCAAGGACTTAATTTATACAC-3’, antisense 5’-CTGTTCGGGAGGGAATCAC-3’; GAPDH, sense: 5’-CCCTTCATTGACCTCAACTACATG-3’ and antisense: 5’-TGGGATTTCCATTGATGACAAGC-3’ (Invitrogen, Monza, Italy). All samples were analysed in duplicate and averaged. The relative expression of the target gene was normalized to the level of GAPDH in the same cDNA.

PCA and TFag were assayed after a 18 h incubation period while TFmRNA was evaluated after a 2 h interval. BAY 10–772, NAC and anti-GGT polyclonal antibody were added 30 min prior to GGT stimulation.

PCA, ELISA and Q-PCR results in each control and experimental group were all generated from suspensions containing equal number of cells (3×106 PBMCs/mL).

Statistics

Statistical differences were tested by Mann–Whitney test. Data were reported as means ± SD unless otherwise reported. A two-tailed p-level <0.05 was the threshold for statistical significance.

Results

GGT stimulates TF expression independent of its enzymatic properties

Equine GGT (100 mU/mL) stimulated TF PCA, an effect insensitive to GGT inhibition by acivicin (10−4M) (Fig. 2). Incubation of the samples with an antihuman TF antibody (30 μg/mL; IgG, American Diagnostica) abolished more than 95 % of the PCA indicating its dependence upon TF (data not shown).
Fig. 2

PCA stimulation by equine GGT (100 mU/mL), an effect insensitive to acivicin (ACI, 10−4), a GGT inhibitor [20], and abolished by heat inactivation of the enzyme. Means ± SD, n = 6, * p < 0.001 vs baseline. Baseline PCA refer to values ≤0.01 AU

hrGGT, an enzymatically inactive protein induced a graded, concentration-dependent PCA stimulation without evidence of a plateau (Fig. 3, left panel). As a comparison, PCA in response to the peak hrGGT concentration (1.0 μg/mL) used in those studies was in the range obtained under identical experimental conditions by a well characterized procoagulant agonist such as LPS at a standard concentration of 0.1 μg/mL (from 0.01 ± 0.008 to 1.12 ± 0.2 AU) [13].
Fig. 3

Left panel: Concentration-dependent increase in PCA in response to hrGGT, an enzymatically inactive protein. Means ± SD, n = 7, $ p < 0.05 and * p < 0.001 vs baseline (B). Right panel: Time course of PCA in PBMCs stimulated by hrGGT, 0.5 μg/mL (■), as compared to quiescent cell preparations (▲). Means, n = 4. Baseline PCA refer to values ≤0.01 AU

Taking into account its equieffectiveness to natural GGT, 100 mU/mL, all further studies were carried out with hrGGT, 0.5 μg/mL, and the time course of its effect on PCA is reported in Fig. 3, right panel.

LPS contamination does not explain GGT-induced TF expression

Heat inactivation abrogated the effect of either natural GGT (Fig. 2) or hrGGT (data not shown).

LPS determination in hrGGT preparations averaged 0.07 ± 0.02 ng/mL (n = 4 replicates), a concentration that did not affect baseline PCA to a statistically significant extent quite in contrast with hrGGT (Fig. 4, left panel).
Fig. 4

Left panel: Procoagulant effect of LPS concentrations in the contaminant range (0.1 ng/mL) relative to baseline values and hrGGT-primed values. Means ± SD, n = 3, *p < 0.001 vs LPS. Right panel: Inhibition of hrGGT(0.5 μg/mL)-stimulated PCA by a specific anti-hrGGT polyclonal IgG antibody (Ab, 2.5 μg/mL). Means ± SD, n = 7, *p < 0.001 vs hrGGT+ IgG isotype control. Baseline PCA refer to values ≤0.01 AU

hrGGT-induced procoagulant responses were downregulated by an anti-GGT IgG polyclonal antibody (Fig. 4, right panel).

hrGGT induces TF transcription by activating NFkB and increasing ROS generation

hrGGT, 0.5 μg/mL, induced an increase in both TFag and mRNA (Fig. 5, left and right panel). BAY-11-7082 (10−5M) inhibited both GGT-stimulated TF protein and activity (Fig. 6, left and right panel), an inhibitory effect on PCA shared by NAC (10−3M, from 0.35 ± 0.07 to 0.09 ± 0.01, p < 0.001, n = 7).
Fig. 5

Stimulation by hrGGT (0.5 μg/mL) of TFag (left panel) and TFmRNA (right panel). Means ± SD, n = 13 and n = 9 each, *p < 0.001 vs baseline

Fig. 6

Inhibition of hrGGT (0.5 μg/mL)-stimulated PCA (left panel) and TFag (right panel) by BAY11-7082 (10−5M), a NFkB inhibitor [24]. Means ± SD, n = 7each, *p < 0.001 vs hrGGT. Baseline PCA refer to values ≤0.01 AU

Discussion

Discussion of the effects of GGT on TF expression needs some preliminary comments about endotoxin contamination, an important concern in the light of the frequent pollution by that bacterial product of cell cultures even if grown in carefully controlled experimental conditions [22]. However, three orders of considerations make that possibility unlikely. First, GGT-induced PCA was abrogated by heat, a procedure generally ineffective on heat-resistant LPS [21]. Secondly, LPS levels in our preparation were less than <0.1 ng/mL, a concentration with a minor, if any, procoagulant action and certainly far less than that of GGT, a behaviour excluding an important role for heat-sensitive LPS strains [22]. Thirdly, inhibition of TF activity by an anti-GGT antibody provided additional proof of the specificity of the procoagulant response to hrGGT.

Having this background in mind, the main and original outcome of this study was the demonstration of the procoagulant properties of GGT and their independence from the enzymatic action of the molecule. That latter, quite intriguing conclusion is based upon the insensitivity of natural GGT-stimulated PCA to acivicin, a highly specific GGT inhibitor [20] and, more importantly, by the maintained procoagulant effect of hrGGT, a wheat germ-derived protein devoid of enzymatic activity because of a missing post-translational glycosylation apparatus [17, 18], an assumption fully verified by our GSH hydrolysis experiments reported in Fig. 1. Thus, hrGGT induced a concentration-dependent procoagulant effect, increased TFag and upregulated mRNA, a behaviour this latter showing that GGT-induced TF gene transcription is an early event since our mRNA assays were obtained after only 2 h of exposure to the molecule, quite similar in this regard to the response induced by unrelated cytokines and inflammatory agonists (e.g. [27]). However, additional studies are needed to evaluate the pattern of GGT-induced gene expression over a longer time course and the reader should also be aware that our PCR procedure based upon the use of GAPDH as a single and quite variable reference gene may present some technical limitations [28, 29]. Moreover, GGT-induced TF gene transcription was likely located at the level of NFkB activation given the inhibitory effect of BAY-10-772, a pharmacological antagonist [24] of that crucial controller of redox stimuli converging upon TF gene [7, 8]. The conclusion was strengthened by the negative modulation of PCA exerted by NAC, a sulfhydryl-group donor that, by increasing the antioxidant thiol pool and scavenging the excess of intracellular ROS, downregulates NFkB [25]. Therefore, our data, besides constituting, to the best of our knowledge, the first demonstration of a direct TF procoagulant effect of GGT, also provide consistent, albeit admittedly indirect, evidence for increased ROS production and NFkB activation as the pathophysiological mechanism linking GGT to TF expression in PBMCs.

That GGT might induce ROS generation is a concept dating back to two decades ago or so when Glass and Stark showed oxidative damage of cell surface proteins and membrane lipids as a consequence of GSH cleavage by GGT inducing auto-oxidation of the sulfur via a Fenton reaction resulting in the iron–dependent production of oxygen radicals [30]. However, that mechanism, which requires an enzymatically functional GGT molecule, cannot evidently apply to our data. Rather, direct, non enzymatic TF stimulation is closely consonant with similar results obtained in evaluating the role of the GGT as a bone resorbing factor [31]. The data open obvious questions about the GGT-operated signal transduction pathways upstream NFkB activation including the mechanisms allowing membrane permeation of the exogenous protein and the interaction with its intracellular targets. Although our results cannot answer this specific point, one might conjecture of a specific but insofar not identified GGT-receptor or lipid-driven endocytosis [32]. Perhaps, some role may play a chemokine-like CX3C motif contained in the GGT molecule [33] or exogenous GGT might mimick cytokine-like activities of GGT-related proteins produced by genes different from the GGT1 [34]. For example, the GGT2 gene located close to the GGT1 chromosomal region seems to encode for a full length, enzymatically inactive protein, not localized to the plasma membrane [35] and, according to some Authors, involved in redox modulation [36]. It might also be possible to envisage protein-protein interactions leading to the expression of other procoagulant cytokines. Additional unresolved questions to be addressed in future studies regard an understanding of how the enzymatic and non-enzymatic activity of GGT may complement each other as well as the role of circulating GGT levels in the activation of the TF procoagulant pathway.

The data reported in this study may have pathophysiological and clinical relevance. In fact, previous experiments have shown upregulated GGT transcription in response to NADPH oxidase-mediated ROS generation [37] as well as to agents endowed with TF-stimulating properties [8] such as Tumor Necrosis Factor(TNF)-alpha [38] and phorbol esters [39]. Moreover, monocytes, a cell line harbouring GGT [2, 3], have recently been shown to release a GGT fraction when exposed to LPS [40], a product of Gram-negative bacteria that initiates the pathogen-induced inflammatory response [41] of which activation of coagulation is a prominent component [9]. In that framework, thus, it is conceivable to hypothesize a vicious circle by which circulating or within-plaque [12, 40] GGT stimulates TF expression, and plaque-derived cytokines induce procoagulant GGT expression [38]. Both arms of this self-reverberating mechanism hinging around NFkB activation [42] may amplify the pro-thrombotic potential of vulnerable atheromatous plaques possibly in synergism with TF expressed by activated B- and T-lymphocytes [14, 43], a tempting but at the moment only speculative hypothesis worth being pursued in future studies.

Conclusions

Our data provide the first evidence of a procoagulant action of GGT, a result that adds to the long [8] and enlarging (e.g. [44, 45]) list of TF-inducing agents acting through NFkB activation. In showing the independence of that effect from its enzymatic activity, the data raise the issue of the proinflammatory and prothrombotic potential of GGT as a cytokine-like protein. However, further work is needed to understand more precisely the extent to which in-vitro data can be transferred to in-vivo conditions and the possible pathophysiological importance of this mechanism in cardiovascular risk modulation.

Abbreviations

ag: 

Antigen

AU: 

Arbitrary Units

CaCl2

Calcium Chloride

DNA: 

Deoxyribonucleic acid

ELISA: 

Enzyme-linked immunosorbent assay

GAPDH: 

Glyceraldehyde-3-phosphate dehydrogenase

GGT: 

Gamma-glutamyltransferase

GSH: 

Glutathione

Hr: 

Human recombinant

Ig: 

Immunoglobulin

LAL: 

Limulus Amebocyte Lysate

LPS: 

Lipopolysaccharide

MTT: 

Dimethyl thiazolyl diphenyl tetrazolium

NAC: 

N-acetyl-L-cysteine

NADP: 

Nicotinamide adenine dinucleotide phosphate

NFkB: 

Nuclear factor kappa-light-chain-enhancer of activated B cells

PBMC: 

Peripheral Blood Mononuclear Cell

PCA: 

Procoagulant activity

PCR: 

Polymerase Chain Reaction

RNA: 

Deoxyribonucleic acid

ROS: 

Reactive Oxygen Species

RPMI: 

Roswell Park Memorial Institute

SD: 

Standard deviation

TF: 

Tissue Factor

TNF: 

Tumour Necrosis Factor

Declarations

Acknowledgements

Not applicable.

Funding

Funding for the study was provided by grants from Università degli Studi di Pisa. All Authors are part of the teaching and research staff of the Università degli Studi di Pisa.

Availability of data and materials

The datasets during and/or analysed during the current study available from the corresponding author on reasonable request.

Authors’ contributions

VS carried out the PCA studies; CB carried out the TF antigen experiments; VC carried out the PCR gene expression; AC & MF performed the statistical analysis, SC & TN drafted the manuscript; RZ, AC & AP participated in design of the study; RP conceived the study and coordinated the research team. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Collection of buffy coats from donors and their subsequent processing was approved by the ethics committee of the Azienda Ospedaliero Universitaria Pisana.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell’Area Critica, Università di Pisa
(2)
Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa

References

  1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263–355.View ArticlePubMedGoogle Scholar
  2. Täger M, Ittenson A, Franke A, Frey A, Gassen HG, Ansorge S. Gamma-Glutamyl transpeptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Ann Hematol. 1995;70:237–42.View ArticlePubMedGoogle Scholar
  3. Novogrodsky A, Tate SS, Meister A. Gamma-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc Natl Acad Sci U S A. 1976;73:2414–8.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Paolicchi A, Dominici S, Pieri L, Maellaro E, Pompella A. Glutathione catabolism as a signaling mechanism. Biochem Pharmacol. 2002;64:1027–35.View ArticlePubMedGoogle Scholar
  5. Accaoui MJ, Enoiu M, Mergny M, Masson C, Dominici S, Wellman M, et al. Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-kB. Biochem Biophys Res Commun. 2000;276:1062–7.View ArticlePubMedGoogle Scholar
  6. Dominici S, Visvikis A, Pieri L, Paolicchi A, Valentini MA, Comporti M, et al. Redox modulation of NF-kappaB nuclear translocation and DNA binding in metastatic melanoma. The role of endogenous and gamma-glutamyl transferase-dependent oxidative stress. Tumori. 2003;89:426–33.PubMedGoogle Scholar
  7. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992;17:221–37.View ArticlePubMedGoogle Scholar
  8. Camerer E, Kolstø AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res. 1996;81:1–41.View ArticlePubMedGoogle Scholar
  9. Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109:2698–704.View ArticlePubMedGoogle Scholar
  10. Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Atherosclerosis. 2014;236:7–17.View ArticlePubMedGoogle Scholar
  11. Tatsumi K, Mackman N. Tissue factor and atherothrombosis. J Atheroscler Thromb. 2015;22:543–9.View ArticlePubMedGoogle Scholar
  12. Pucci A, Franzini M, Matteucci M, Ceragioli S, Marconi M, Ferrari M, et al. b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. Atherosclerosis. 2014;237:307–13.View ArticlePubMedGoogle Scholar
  13. Balia C, Petrini S, Scalise V, Neri T, Carnicelli V, Cianchetti S, et al. Compound 21, a selective angiotensin II type 2 receptor agonist, downregulates lipopolysaccharide-stimulated tissue factor expression in human peripheral blood mononuclear cells. Blood Coagul Fibrinolysis. 2014;25:501–6.View ArticlePubMedGoogle Scholar
  14. Mechiche H, Cornillet-Lefebvre P, Nguyen P. A subpopulation of human B lymphocytes can express a functional Tissue Factor in response to phorbol myristate acetate. Thromb Haemost. 2005;94:146–54.PubMedGoogle Scholar
  15. Camera M, Brambilla M, Facchinetti L, Canzano P, Spirito R, Rossetti L, et al. Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res. 2012;129:279–84.View ArticlePubMedGoogle Scholar
  16. Franzini M, Bramanti E, Ottaviano V, Ghiri E, Scatena F, Barsacchi R, et al. A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem. 2008;374:1–6.View ArticlePubMedGoogle Scholar
  17. West MB, Segu ZM, Feasley CL, Kang P, Klouckova I, Li C, Novotny MV, et al. Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue. J Biol Chem. 2010;285:29511–24.View ArticlePubMedPubMed CentralGoogle Scholar
  18. West MB, Wickham S, Quinalty LM, Pavlovicz RE, Li C, Hanigan MH. Autocatalytic cleavage of human gamma-glutamyl transpeptidase is highly dependent on N-glycosylation at asparagine 95. J Biol Chem. 2011;286:28876–88.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem. 1990;190:360–5.View ArticlePubMedGoogle Scholar
  20. Smith TK, Ikeda Y, Fujii J, Taniguchi N, Meister A. Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases. Proc Natl Acad Sci U S A. 1995;14(92):2360–4.View ArticleGoogle Scholar
  21. Majde JA. Endotoxin detection. Immunol Today. 1992;13:328–9.View ArticlePubMedGoogle Scholar
  22. Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem. 2003;278:174–9.View ArticlePubMedGoogle Scholar
  23. Lindsay GK, Roslansky PF, Novitsky TJ. Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin. J Clin Microbiol. 1989;27:947–51.PubMedPubMed CentralGoogle Scholar
  24. García MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E. Inhibition of NF-kappaB activity by BAY 11–7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res. 2005;29:1425–34.View ArticlePubMedGoogle Scholar
  25. Renard P, Zachary MD, Bougelet C, Mirault ME, Haegeman G, Remacle J, et al. Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation. Biochem Pharmacol. 1997;53:149–60.View ArticlePubMedGoogle Scholar
  26. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91:8767–71.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Mueller J, Rox JM, Madlener K, Poetzsch B. Quantitative tissue factor gene expression analysis in whole blood: development and evaluation of a real-time PCR platform. Clin Chem. 2004;50:245–7.View ArticlePubMedGoogle Scholar
  28. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.View ArticlePubMedGoogle Scholar
  29. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004;37:112–4. 116, 118–9.PubMedGoogle Scholar
  30. Glass GA, Stark AA. Promotion of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: the requirement for iron and the effects of antioxidants and antioxidant enzymes. Environ Mol Mutagen. 1997;29:73–80.View ArticlePubMedGoogle Scholar
  31. Niida S, Kawahara M, Ishizuka Y, Ikeda Y, Kondo T, Hibi T, et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J Biol Chem. 2004;279:5752–6.View ArticlePubMedGoogle Scholar
  32. Schubert T, Römer W. How synthetic membrane systems contribute to the understanding of lipid-driven endocytosis. Biochim Biophys Acta. 2015;1853(11Pt B):2992–3005.View ArticlePubMedGoogle Scholar
  33. Kinlough CL, Poland PA, Bruns JB, Hughey RP. Gamma-glutamyltranspeptidase: disulfide bridges, propeptide cleavage, and activation in the endoplasmic reticulum. Methods Enzymol. 2005;401:426–49.View ArticlePubMedGoogle Scholar
  34. Heisterkamp N, Groffen J, Warburton D, Sneddon TP. The human gamma-glutamyltransferase gene family. Hum Genet. 2008;123:321–32.View ArticlePubMedGoogle Scholar
  35. West MB, Wickham S, Parks EE, Sherry DM, Hanigan MH. Human GGT2 does not autocleave into a functional enzyme: A cautionary tale for interpretation of microarray data on redox signaling. Antioxid Redox Signal. 2013;19:1877–88.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Moon DO, Kim BY, Jang JH, Kim MO, Jayasooriya RG, Kang CH, Choi YH, Moon SK, Kim WJ, Ahn JS, Kim GY. K-RAS transformation in prostate epithelial cell overcomes H2O2-induced apoptosis via upregulation of gamma-glutamyltransferase-2. Toxicol In Vitro. 2012;26:429–34.View ArticlePubMedGoogle Scholar
  37. Ravuri C, Svineng G, Pankiv S, Huseby NE. Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of γ-glutamyltransferase expression. Free Radic Res. 2011;45:600–10.View ArticlePubMedGoogle Scholar
  38. Reuter S, Schnekenburger M, Cristofanon S, Buck I, Teiten MH, Daubeuf S, et al. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol. 2009;77:397–411.View ArticlePubMedGoogle Scholar
  39. Pandur S, Ravuri C, Moens U, Huseby NE. Combined incubation of colon carcinoma cells with phorbol ester and mitochondrial uncoupling agents results in synergic elevated reactive oxygen species levels and increased γ-glutamyltransferase expression. Mol Cell Biochem. 2014;388:149–56.View ArticlePubMedGoogle Scholar
  40. Belcastro E, Franzini M, Cianchetti S, Lorenzini E, Masotti S, Fierabracci V, Pucci A, et al. Monocytes/macrophages activation contributes to b-gamma-glutamyltransferase accumulation inside atherosclerotic plaques. J Transl Med. 2015;13:325. doi:10.1186/s12967-015-0687-6.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol. 2003;74:479–85.View ArticlePubMedGoogle Scholar
  42. Ritchie ME. Nuclear Factor-kB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 1998;98:1707–13.View ArticlePubMedGoogle Scholar
  43. De Palma R, Cirillo P, Ciccarelli G, Barra G, Conte S, Pellegrino G, et al. Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? Int J Cardiol. 2016;218:188–95.View ArticlePubMedGoogle Scholar
  44. Napoleone E, Di Santo A, Amore C, Baccante G, di Febbo C, Porreca E, et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost. 2007;5:1462–8.View ArticlePubMedGoogle Scholar
  45. Calabrò P, Cirillo P, Limongelli G, Maddaloni V, Riegler L, Palmieri R, et al. Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-ĸB-dependent pathway. J Vasc Res. 2011;48:59–66.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement